Journal
RAPID COMMUNICATIONS IN MASS SPECTROMETRY
Volume 27, Issue 6, Pages 655-670Publisher
WILEY-BLACKWELL
DOI: 10.1002/rcm.6488
Keywords
-
Funding
- Australian Research Council [LP110100693]
- Ovarian Cancer Research Foundation
- Government of South Australia
- Bioplatforms Australia
- Australian Research Council [LP110100693] Funding Source: Australian Research Council
Ask authors/readers for more resources
RATIONALE Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry provides the means to map the in situ distribution of tryptic peptides in formalin-fixed clinical tissue samples. The ability to analyze clinical samples is of great importance to further developments in the imaging field. However, there is a requirement in this field of research for additional methods describing the characterization of tryptic peptides by MALDI imaging. METHODS AND RESULTS This protocol gives highly detailed instructions, with examples, for (1) successfully performing tryptic peptide MALDI imaging on formalin-fixed cancer tissue using a MALDI-TOF/TOF MS instrument, (2) tentatively generating identifications through nLC/MS/MS, and (3) validating these identifications by in situ MS/MS of peptides of interest. CONCLUSIONS This protocol provides a detailed and straightforward description of the methods required for groups new to MALDI imaging to begin analysis of formalin-fixed clinical samples. Copyright (c) 2013 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available